January 30, 2017
Nippon Chemiphar and Nagase Medicals said on January 27 that they have won a patent infringement suit filed in Japan by Swiss-based Debiopharm International SA over the anticancer agent Elplat (oxaliplatin). In the suit, filed with the Tokyo District Court,...read more